What Weed Means for the Future of Sustainable Healthcare
Written by DAVID BIENENSTOCK
Despite costing the average MS patient in New Zealand more than $16,500 (USD) per year, Sativex contains relatively modest doses of THC and CBD, and no other active ingredients—an incredible marijuana mark-up that gives GW a strong incentive to help maintain cannabis prohibition at all costs, especially since whole-plant cannabis can be smoked or vaporized, bringing near instantaneous relief due to rapid absorption in the lungs, while Sativex takes an hour or longer to start working.
“Needless to say, the pharmaceutical industry is increasingly devoting its massive resources to the development of cannabinoid analogs or other products which can compete with herbal marijuana,” Dr. Grinspoon writes. “None of these products will be as inexpensive or useful as herbal marijuana. Legality, not efficacy, is their major appeal.”
Hemp Can Save the Planet
- Ottawa takes steps to deregulate hemp farming
- Irish Government passes medicinal cannabis bill without vote
- Cambodia – Prospect for a budding industry
- South Africa on track to Legalize Medical Cannabis
- Puerto Rico Ends Cannabis Drug Testing in Public Sector
Help Support JackHerer.com
If you would like to make a donation, thank you.